Vietnam To Outperform Cambodia In Clinical Trials Sector

BMI View: Over the short and medium term, we do not expect Vietnam and Cambodia to interest clinical trials organisations (CROs) significantly, unless improvements are made to their regulatory processes. Comparing the two South East Asian countries, we expect Vietnam to generate more interest among investors as there is some form of regulation improvement in the country.

To read the full article, please choose one of the following options: